OICR Reports Pilot Data from Clinical Sequencing Study; Switching from PacBio to MiSeq in Second Stage | GenomeWeb

The Ontario Institute of Cancer Research has published an interim report of a pilot project to evaluate targeted sequencing of cancer patients with metastatic or recurrent disease to influence clinical care.

The group enrolled more than 80 patients in the pilot phase of the study, sequencing 19 known cancer genes using the Pacific Biosciences RS and validating the results with Sequenom's OncoCarta panel, which tests for 238 mutations in the same 19 genes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.